The complete package for COVID-19 diagnostics

Our product portfolio for SARS-CoV-2 provides you with the appropriate tools to answer all your diagnostic questions. It comprises two PCR tests, an antigen ELISA for acute diagnostics, several serological tests for differentiated detection of antibodies (IgA, IgM, IgG) against different SARS-CoV-2 antigens, a surrogate virus neutralisation test and an interferon-gamma release assay. The detection of specific anti-SARS-CoV-2 IgG using ELISA can be performed using not only venous blood samples, but also dried capillary blood (dried blood spots – DBS).

All tests are CE-marked. Moreover, the Anti-SARS-CoV-2 ELISA (IgG) and the EURORealTime SARS-CoV-2 have been approved for use in authorised laboratories by the U.S. Food and Drug Administration (FDA) via an Emergency Use Authorization (EUA)
Please consider the current US-specific instruction for use of the respective test system for validity of the FDA EUA.

RT-PCR and antigen test

Suitable for acute COVID-19 diagnostics

Direct detection of the virus via RNA (RT-PCR) or viral antigens (ELISA) allow reliable identification of acute SARS-CoV-2 infections. With the EURORealTime SARS-CoV-2 and the EURORealTime SARS-CoV-2/Influenza A/B, EUROIMMUN offers a single-parameter test for detection of the virus as well as a combination test for parallel detection of SARS-CoV-2 and influenza virus types A and B as well as for differentiation between these viruses. Additionally, the antigen ELISA enables detection of the viral nucleocapsid protein in swabs from patients with acute infections.

Antibody tests

For evaluation of the humoral immune response to SARS-CoV-2

The portfolio contains several ELISAs and one immunoblot for the detection of antibodies against modified nucleocapsid protein (IgM and IgG) and against the domains S1 and S2 of the spike protein (IgA and IgG). The S1-based ELISA is available as Anti-SARS-CoV-2 QuantiVac ELISA (IgG), including 6 calibrators for quantification of the antibody concentration. It is the first test that also allows issuing of the results in standardised units (BAU/ml). The serological product range is supplemented by the SARS-CoV-2 NeutraLISA, a surrogate virus neutralisation test for the detection of neutralising anti-S1/RBD antibodies, and the interferon-gamma release assay Quan-T-Cell for determination of the activity of SARS-CoV-2-reactive T cells. Both test systems are useful tools for evaluation of the immune response after infection with SARS-CoV-2 or vaccination with vaccines based on the spike protein. With the IgG ELISAs, dried capillary blood (dried blood spots, DBS) can be used as sample material, besides venous blood.


Customer feedback & references

The ELISAs are used worldwide by renowned diagnostic laboratories, reference institutes, clinics and research institutions in order to diagnose and investigate COVID-19.

Customer feedback & publications

Blood collection set

For easy collection of blood samples from the fingertip

The Blood collection set contains all materials that are required for sample collection and mailing of dried capillary blood samples (dried blood spots – DBS). It is suitable either for personal use in a home environment or for blood collection performed by a healthcare professional. The subsequent investigation of the samples for specific IgG antibodies against SARS-CoV-2 is performed in a laboratory.


Information material

Download flyers and further information material here.